Literature DB >> 17006753

Acute renal failure associated with gefitinib therapy.

Hsiang-Lin Wan, Nai-Shun Yao.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17006753     DOI: 10.1007/s00408-005-2581-0

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


× No keyword cloud information.
  4 in total

1.  Side effects of therapy: case 1. Nephrotic syndrome associated with gefitinib therapy.

Authors:  Ryuichiro Kumasaka; Norio Nakamura; Kenichi Shirato; Hiroshi Osawa; Shingo Takanashi; Yukihiro Hasegawa; Hideaki Yamabe; Masayuki Nakamura; Michiko Tamura; Ken Okumura
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

2.  Safety profile of gefitinib in advanced non-small cell lung cancer elderly patients with chronic renal failure: two clinical cases.

Authors:  Antonio Rossi; Paolo Maione; Filomena Del Gaizo; Ciro Guerriero; Vincenzo Castaldo; Cesare Gridelli
Journal:  Lung Cancer       Date:  2005-03       Impact factor: 5.705

3.  Severe acute interstitial pneumonia and gefitinib.

Authors:  Akira Inoue; Yasuo Saijo; Makoto Maemondo; Kazunori Gomi; Yutaka Tokue; Yuichiro Kimura; Masahito Ebina; Toshiaki Kikuchi; Takuya Moriya; Toshihiro Nukiwa
Journal:  Lancet       Date:  2003-01-11       Impact factor: 79.321

4.  Gefitinib as a last treatment option for non-small-cell lung cancer: durable disease control in a subset of patients.

Authors:  A Haringhuizen; H van Tinteren; H F R Vaessen; P Baas; N van Zandwijk
Journal:  Ann Oncol       Date:  2004-05       Impact factor: 32.976

  4 in total
  8 in total

Review 1.  Chemotherapy-associated renal dysfunction.

Authors:  Vaibhav Sahni; Devasmita Choudhury; Ziauddin Ahmed
Journal:  Nat Rev Nephrol       Date:  2009-06-30       Impact factor: 28.314

2.  A case of gefitinib-associated membranous nephropathy in treatment for pulmonary adenocarcinoma.

Authors:  Tomohiro Kaneko; Akira Shimizu; Michiko Aoki; Shuichi Tsuruoka
Journal:  CEN Case Rep       Date:  2014-07-18

Review 3.  Renal effects of targeted anticancer therapies.

Authors:  Camillo Porta; Laura Cosmai; Maurizio Gallieni; Paolo Pedrazzoli; Fabio Malberti
Journal:  Nat Rev Nephrol       Date:  2015-03-03       Impact factor: 28.314

Review 4.  Renal toxicity of anticancer agents targeting HER2 and EGFR.

Authors:  Laura Cosmai; Maurizio Gallieni; Camillo Porta
Journal:  J Nephrol       Date:  2015-09-04       Impact factor: 3.902

5.  Minimal change disease onset observed after bevacizumab administration.

Authors:  Ramy M Hanna; Eduardo Lopez; James Wilson; Shrinath Barathan; Arthur H Cohen
Journal:  Clin Kidney J       Date:  2015-12-28

Review 6.  Adverse Renal Effects of Novel Molecular Oncologic Targeted Therapies: A Narrative Review.

Authors:  Kenar D Jhaveri; Rimda Wanchoo; Vipulbhai Sakhiya; Daniel W Ross; Steven Fishbane
Journal:  Kidney Int Rep       Date:  2016-09-21

7.  Gefitinib-induced hemorrhagic cystitis and inflammatory contracted bladder in a patient with advanced lung adenocarcinoma harboring compound epidermal growth factor receptor G719S and S768I missense mutations: a case report.

Authors:  Xueli Bai; Jiande Cheng; Lifen Zhao; Mengyu Cheng
Journal:  Ann Transl Med       Date:  2022-07

Review 8.  Management of acute kidney injury in gastrointestinal tumor: An overview.

Authors:  Yi-Qi Su; Yi-Yi Yu; Bo Shen; Feng Yang; Yu-Xin Nie
Journal:  World J Clin Cases       Date:  2021-12-16       Impact factor: 1.337

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.